ScottM.BradfieldMD, MBA

Pediatric Hematology & Oncology • Jacksonville, FL

Interim Division Chief of Pediatric Hematology/Oncology at Nemours Children's Specialty Care, Jacksonville

Join to view full profile

Dr. Bradfield is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Connect with other colleagues in the same hospital or clinic
Search all U.S. specialist profiles and refer a patient
Read the latest clinical news and earn CME/CEU credits

See Dr. Bradfield's full profile

Already have an account?

Office
Nemours Children's Specialty Care
807 Children's Way
Jacksonville, FL 32207
Phone+1 904-697-3793
Is this information wrong?

Education & Training

University of MassachusettsMasters of Business Administration (MBA), Concentration in Medical Management, Phi Kappa Phi inductee, 2010 - 2014
University of WashingtonFellowship, Pediatric Hematology/Oncology, 2000 - 2003
Massachusetts General HospitalResidency, Pediatrics, 1997 - 2000
University of South Florida College of MedicineClass of 1997, MD, 2nd in class; AOA junior year inductee
Duke UniversityBS, Psychology, Pre-med, Cum Laude, 1989 - 1993

Certifications & Licensure

FL State Medical License 2003 - 2025
American Board of Pediatrics Pediatrics
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

Top Doctors Jacksonville Magazine, 2019
Phi Kappa Phi inductee University of Massachusetts, Amherst chapter, 2014
Beta Gamma Sigma inductee, International Honor Society for Business Programs University of Massachusetts, Amherst, 2014
Highest Patient Satisfaction for Nemours Enterprise Nemours Children's Specialty Care, 2011
Merit Award ASCO, 2003 Annual Meeting, 2003
Doctor's Doctor Award, 4th Year Medical Student the graduating class would most like to have as their doctor University of South Florida, 1997
Director's Award, Most Promising 4th year medical student entering Academic Oncology H. Lee Moffitt Cancer Center, 1997
Alpha Omega Alpha, junior year inductee AOA, 1996
Regional Top Doctor Castle Connolly, 2014
Join now to see all

Clinical Trials

Isotretinoin With or Without Dinutuximab, Aldesleukin, and Sargramostim Following Stem Cell Transplant in Treating Patients With Neuroblastoma Start of enrollment: 2001 Oct 18
Active, not recruiting
Phase 3
Genetic Analysis in Identifying Late-Occurring Complications in Childhood Cancer Survivors Start of enrollment: 2004 Mar 25
Recruiting
Glutamic Acid in Reducing Nerve Damage Caused by Vincristine in Young Patients With Cancer Start of enrollment: 2007 May 01
Completed
Phase 3
Neuropsychological and Behavioral Testing in Younger Patients With Cancer Start of enrollment: 2009 Feb 27
Recruiting
Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer Start of enrollment: 2009 Sep 14
Active, not recruiting
Phase 3
Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Start of enrollment: 2010 Aug 09
Completed
Temozolomide and Irinotecan Hydrochloride With or Without Bevacizumab in Treating Young Patients With Recurrent or Refractory Medulloblastoma or CNS Primitive Neuroectodermal Tumors Start of enrollment: 2010 Nov 22
Completed
Phase 2
Combination Chemotherapy in Treating Patients With Non-Metastatic Extracranial Ewing Sarcoma Start of enrollment: 2010 Nov 22
Active, not recruiting
Phase 3
Vincristine, Dexamethasone, Doxorubicin, and PEG-asparaginase (VPLD) and Metformin for Relapsed Childhood Acute Lymphoblastic Leukemia (ALL) Start of enrollment: 2011 Jul 18
Completed
Phase 1
Modafinil in Treating Children With Memory and Attention Problems Caused by Cancer Treatment for a Brain Tumor Start of enrollment: 2011 Aug 01
Completed
Phase 2
Caspofungin Acetate, Fluconazole, or Voriconazole in Preventing Fungal Infections in Patients Following Donor Stem Cell Transplant Start of enrollment: 2013 Mar 21
Completed
Phase 3
Metformin in Children With Relapsed or Refractory Solid Tumors Start of enrollment: 2012 Sep 24
Completed
Phase 1
Sorafenib and Topotecan in Refractory/Recurrent Pediatric Malignancies Start of enrollment: 2013 Jan 01
Completed
Phase 1
Irinotecan Hydrochloride and Temozolomide With Temsirolimus or Dinutuximab in Treating Younger Patients With Refractory or Relapsed Neuroblastoma Start of enrollment: 2013 Feb 12
Completed
Phase 2
Blood Sample Markers of Reproductive Hormones in Assessing Ovarian Reserve in Younger Patients With Newly Diagnosed Lymphomas Start of enrollment: 2013 Jun 17
Active, not recruiting
Chlorhexidine Gluconate Cleansing in Preventing Central Line Associated Bloodstream Infection and Acquisition of Multi-drug Resistant Organisms in Younger Patients With Cancer or Undergoing Donor Stem Cell Transplant Start of enrollment: 2013 Nov 04
Completed
Phase 3
Busulfan, Cyclophosphamide, and Melphalan or Busulfan and Fludarabine Phosphate Before Donor Hematopoietic Cell Transplant in Treating Younger Patients With Juvenile Myelomonocytic Leukemia Start of enrollment: 2013 Jun 24
Completed
Phase 2
Risk-Based Therapy in Treating Younger Patients With Newly Diagnosed Liver Cancer Start of enrollment: 2009 Sep 01
A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia Start of enrollment: 2019 Jul 03
Recruiting
Phase 3
Studying the Effect of Levocarnitine in Protecting the Liver From Chemotherapy for Leukemia or Lymphoma Start of enrollment: 2023 Aug 14
Recruiting
Phase 3
Roles: Contact, Principal Investigator
Join now to see all

Publications & Presentations

PubMed

3 citations
Impact of social disparities on 10 year survival rates in paediatric cancers: a cohort study.
Victor Chalfant, Carlos Riveros, Scott M Bradfield, Andrew A Stec> ;Lancet Regional Health. Americas. 2023 Apr 1
1 citations
Trends in Pediatric Cancer Care in Florida From 1981-2020: Changing Patterns in a Growing and Increasingly Diverse Population.
Peter H Shaw, Jonathan Metts, Ernest Amankwah, Don E Eslin, Scott Bradfield, William B Slayton, Brian Hays, Brian Calkins, Juan Rico, Jeffrey Krischer> ;Cureus. 2023 Feb 1
2 citations
Modern Therapy for Chest Wall Ewing Sarcoma: An Update of the University of Florida Experience.
Daniel J Indelicato, Raymond B Mailhot Vega, Emma Viviers, Christopher G Morris, Scott M Bradfield, C Parker Gibbs, Julie A Bradley> ;International Journal of Radiation Oncology, Biology, Physics. 2022 Jun 1
2 citations
Modern Therapy for Spinal and Paraspinal Ewing Sarcoma: An Update of the University of Florida Experience.
Daniel J Indelicato, Raymond B Mailhot Vega, Emma Viviers, Christopher G Morris, Scott M Bradfield, Nathan J Ranalli, Julie A Bradley> ;International Journal of Radiation Oncology, Biology, Physics. 2022 May 1
2 citations
A phase I study of irinotecan and temozolomide with bevacizumab in children with recurrent/refractory central nervous system tumors.
Jonathan Metts, Brittany Harrington, Emad Salman, Scott M Bradfield, Jennifer Flanary, Maua Mosha, Ernest Amankwah, Stacie Stapleton> ;Child's Nervous System. 2022 May 1
3 citations
Proton radiotherapy for infant rhabdomyosarcoma: Rethinking young age as an adverse prognostic factor.
A. Parekh, Daniel J. Indelicato, Raymond B. Mailhot Vega, Ronny L Rotondo, Christopher G. Morris, Scott Bradfield, Julie A. Bradley> ;Radiotherapy and Oncology. 2021 May 21
18 citations
Pleuropulmonary blastoma-like peritoneal sarcoma: a newly described malignancy associated with biallelic DICER1 pathogenic variation.
Kris Ann P. Schultz, Alexander Nelson, Anne K. Harris, Mike Finch, Amanda Field, Jason A. Jarzembowski, Mercedes Wilhelm, William A. Mize, Portia A. Kreiger, Katrina C...> ;Modern Pathology. 2020 May 15
15 citations
Treatment Outcomes After Proton Therapy for Ewing Sarcoma of the Pelvis.
Haruka Uezono, Daniel J. Indelicato, Ronny L. Rotondo, Raymond B. Mailhot Vega, Scott Bradfield, Christopher G. Morris, Julie A. Bradley> ;International Journal of Radiation Oncology, Biology, Physics. 2020 Aug 1
9 citations
Outcomes Following Proton Therapy for Group III Pelvic Rhabdomyosarcoma.
Daniel J. Indelicato, Ronny L. Rotondo, Matthew J. Krasin, Raymond B. Mailhot Vega, Haruka Uezono, Scott Bradfield, Vibhuti Agarwal, Christopher G. Morris, Julie A. Br...> ;International Journal of Radiation Oncology, Biology, Physics. 2020 Apr 1
8 citations
Outcomes following proton therapy for Ewing sarcoma of the cranium and skull base.
Shivam M Kharod, Daniel J. Indelicato, Ronny L. Rotondo, Raymond B. Mailhot Vega, Haruka Uezono, C.G. Morris, Scott Bradfield, Eric Sandler, Julie A. Bradley> ;Pediatric Blood & Cancer. 2020 Feb 1
2 citations
Intravenous and Oral Posaconazole Pharmacokinetics in a Five-Year-Old With Mucor: A Case Report and Review of the Literature.
Matthew O Ruland, Tosha A Egelund, John S Ng, Scott M Bradfield, Eric F. Egelund> ;The Journal of Pediatric Pharmacology and Therapeutics. 2019 Nov 1
4 citations
45 GyRBE for group III orbital embryonal rhabdomyosarcoma.
Daniel J. Indelicato, Ronny L. Rotondo, Raymond B. Mailhot Vega, Haruka Uezono, Scott Bradfield, Vibhuti Agarwal, Marinka L.F. Hol, Julie A. Bradley> ;Acta Oncologica. 2019 Sep 18
Esophagitis associated with multimodality management of pediatric Ewing sarcoma of thorax.
Vibhuti Agarwal, Natalie Logie, Christopher G. Morris, Julie A. Bradley, Ronny L. Rotondo, Scott Bradfield, Daniel J. Indelicato> ;Pediatric Blood & Cancer. 2018 Feb 12
1 citations
False Lung Metastasis: Concurrent Ewing Sarcoma and Minimally Invasive Adenocarcinoma.
Bechtel, A. S., Bechtel, A. S., Cheek, B., Cheek, B., Bradfield, S., Bradfield, S.> ;Journal of pediatric hematology/oncology. 2017 Oct 11
21 citations
Glutamic acid not beneficial for the prevention of vincristine neurotoxicity in children with cancer
Scott Bradfield, Eric Sandler, Thomas J. Geller, Roy N. Tamura, Jeffrey P. Krischer> ;Pediatric Blood & Cancer. 2015 Jun 1
1 citations
Eliciting Parental Values and Preferences in the Medical Decision-Making Process
Alissa Swota, Scott Bradfield> ;The American Journal of Bioethics. 2015 May 13
Pharmacokinetics and safety of intravenous voriconazole to oral switch in immunocompromised children compared to adults.
Driscoll, T. A., Yu, L. C., Frangoul, H., Krance, R. A., Nemecek, E., Blumer, J., Arrieta, A., Graham, M. L., Bradfield, S. M., Baruch, A., Liu, P.> ;Antimicrob Agents Chemother. 2011 Oct 3
2 citations
"STOP"-ping harm: when is state intervention justified?
Alissa Swota, Scott Bradfield> ;Pediatric Blood & Cancer. 2010 Jan 1
36 citations
Topotecan by 21‐day continuous infusion in children with relapsed or refractory solid tumors: A Children's Oncology Group study
Douglas S. Hawkins, Scott Bradfield, James A. Whitlock, Mark Krailo, Janet Franklin, Susan M. Blaney, Peter C. Adamson, Gregory H. Reaman> ;Pediatric Blood & Cancer. 2006 Nov 1
Graft-versus-leukemia effect in acute lymphoblastic leukemia: the importance of tumor burden and early detection.
Bradfield, S. M., Radich, J. P., Loken, M. R.> ;Leukemia. 2004 Jun
41 citations
Fractionated low-dose radiotherapy after myeloablative stem cell transplantation for local control in patients with high-risk neuroblastoma.
Scott M. Bradfield, James G. Douglas, Douglas S. Hawkins, Jean E. Sanders, Julie R. Park> ;Cancer. 2004 Mar 15
21 citations
Prolonged survival after invasive aspergillosis: A single-institution review of 11 cases
Jessica A. Wright, Scott M. Bradfield, Julie R. Park, Douglas S. Hawkins> ;Journal of Pediatric Hematology/oncology. 2003 Apr 1
Join now to see all

Authored Content

Adolescent and Young Adult Oncology: Addressing a NeedJuly 2015
Prevention and Treatment of Infectious DiseaseJuly 2006

Hospital Affiliations

Wolfson Children's HospitalJacksonville, Florida
Nemours Children's Hospital, FloridaOrlando, Florida

External Links

News story on ALL patients in same familyhttps://www.actionnewsjax.com/news/local/youre-going-get-through-siblings-battling-cancer/it-jacksonville-family-had-two-young-siblings-battling-cancer/WBM6ELD6OBCHBJHMOVOF5BWBTI/